SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001005477-03-003556
Filing Date
2003-08-22
Accepted
2003-08-22 21:14:31
Documents
2
Period of Report
2002-10-07

Document Format Files

Seq Description Document Type Size
1 FORM 4 edgar123.html 4  
1 FORM 4 edgar123.xml 4 36416
3 INFORMATION REGARDING JOINT FILERS ex99.txt EX-99 779
  Complete submission text file 0001005477-03-003556.txt   39414
Mailing Address
Business Address 6611 TRIBUTARY ST BALTIMORE MD 21224 4106316300
GUILFORD PHARMACEUTICALS INC (Issuer) CIK: 0000918066 (see all company filings)

IRS No.: 521841960 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address
Business Address C/O HIGHLINE MANAGEMENT LLC 888 SEVENTH AVE NEW YORK NY 10106 2126032600
SACANE SCOTT (Reporting) CIK: 0001160291 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-23736 | Film No.: 03863486

Mailing Address 113 POST RD. EAST WESTPORT CT 06880
Business Address 113 POST RD. EAST VESTPORT CT 06880 2033410667
DURUS CAPITAL MANAGEMENT (Reporting) CIK: 0001166014 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-23736 | Film No.: 03863487